Point72 Hong Kong LTD Igm Biosciences, Inc. Transaction History

Point72 Hong Kong LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$15.42 - $27.01 $3,669 - $6,428	238 New	238 $5,000
Q1 2022 May 16, 2022	SELL	$13.42 - $29.73 $15,419 - $34,159	-1,149 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$27.59 - $66.39 $31,700 - $76,282	1,149 New	1,149 $34,000
Q1 2021 May 17, 2021	SELL	$71.56 - $121.23 $1,932 - $3,273	-27 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$47.41 - $115.03 $2,844 - $6,901	-60 Reduced 68.97%	27 $2,000
Q3 2020 Nov 16, 2020	BUY	$43.0 - $84.01 $3,741 - $7,308	87 New	87 $6,000
Q4 2019 Feb 14, 2020	SELL	$17.25 - $49.51 $119,197 - $342,114	-6,910 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$17.75 - $24.3 $122,652 - $167,913	6,910 New	6,910 $123,000

21.4M

39.5K

16.5K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.